Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/89659
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Temporal changes in blood product usage in preterm neonates born at less than 30 weeks' gestation in Canada
Author: Keir, A.
Yang, J.
Harrison, A.
Pelausa, E.
Shah, P.
Citation: Transfusion, 2015; 55(6):1340-1346
Publisher: Wiley
Issue Date: 2015
ISSN: 0041-1132
1537-2995
Statement of
Responsibility: 
Amy K. Keir, Junmin Yang, Adele Harrison, Ermelinda Pelausa, Prakesh S. Shah, and on Behalf of the Canadian Neonatal Network
Abstract: BACKGROUND: Knowledge of neonatal transfusion practices remains limited to local cohorts or survey-based studies. This study evaluated the pattern and temporal changes in the types and frequency of blood product use among preterm neonates born at less than 30 weeks' gestation in Canada. STUDY DESIGN AND METHODS: A retrospective cohort study of preterm neonates born at less than 30 weeks' gestation and admitted to participating neonatal intensive care units in the Canadian Neonatal Network from 2004 to 2012 was conducted to evaluate blood product usage. The temporal change in red blood cell (RBC) use was evaluated by dividing the study period into three epochs: 2004 to 2006, 2007 to 2009, and 2010 to 2012. RESULTS: Of 14,868 eligible neonates admitted to participating units in Canada during the overall study period, 8252 (56%) received RBCs, 2151 (15%) platelets, 1556 (11%) fresh-frozen plasma, 915 (6%) albumin, and 302 (2%) cryoprecipitate. Temporal evaluation over three epochs revealed a trend toward fewer RBC transfusions among neonates born at 26 to 29 weeks' gestation (p = <0.01-0.04) but use remained unchanged or increased for neonates born at 23 to 25 weeks' gestation (p = 0.02-0.54). CONCLUSION: Blood product use remains at a very high frequency in preterm neonates born at less than 30 weeks' gestation. Evolutionary practice changes and relative high tolerance for anemia may be associated with a reduction in RBC usage in recent years in neonates born at at least 26 weeks' gestation. This contrasts with the ongoing higher usage of blood products observed at extremely low gestational ages.
Keywords: Canadian Neonatal Network
Plasma
Humans
Sepsis
Enterocolitis, Necrotizing
Lung Diseases
Anemia
Infant, Premature, Diseases
Birth Weight
Serum Albumin
Fibrinogen
Factor VIII
Blood Component Transfusion
Retrospective Studies
Gestational Age
Infant, Newborn
Infant, Low Birth Weight
Infant, Premature
Intensive Care Units, Neonatal
Drug Utilization
Canada
Rights: © 2015 AABB
DOI: 10.1111/trf.12998
Appears in Collections:Aurora harvest 7
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.